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Abstract
Background: The molecular events associated with regulation of milk fat synthesis in the bovine
mammary gland remain largely unknown. Our objective was to study mammary tissue mRNA
expression via quantitative PCR of 45 genes associated with lipid synthesis (triacylglycerol and
phospholipids) and secretion from the late pre-partum/non-lactating period through the end of
subsequent lactation. mRNA expression was coupled with milk fatty acid (FA) composition and
calculated indexes of FA desaturation and de novo synthesis by the mammary gland.
Results:  Marked up-regulation and/or % relative mRNA abundance during lactation were
observed for genes associated with mammary FA uptake from blood (LPL, CD36), intracellular FA
trafficking (FABP3), long-chain (ACSL1) and short-chain (ACSS2) intracellular FA activation, de novo
FA synthesis (ACACA, FASN), desaturation (SCD, FADS1), triacylglycerol synthesis (AGPAT6, GPAM,
LPIN1), lipid droplet formation (BTN1A1, XDH), ketone body utilization (BDH1), and transcription
regulation (INSIG1, PPARG, PPARGC1A). Change in SREBF1 mRNA expression during lactation,
thought to be central for milk fat synthesis regulation, was ≤2-fold in magnitude, while expression
of INSIG1, which negatively regulates SREBP activation, was >12-fold and had a parallel pattern of
expression to PPARGC1A. Genes involved in phospholipid synthesis had moderate up-regulation in
expression and % relative mRNA abundance. The mRNA abundance and up-regulation in
expression of ABCG2 during lactation was markedly high, suggesting a biological role of this gene in
milk synthesis/secretion. Weak correlations were observed between both milk FA composition
and desaturase indexes (i.e., apparent SCD activity) with mRNA expression pattern of genes
measured.
Conclusion: A network of genes participates in coordinating milk fat synthesis and secretion.
Results challenge the proposal that SREBF1 is central for milk fat synthesis regulation and highlight
a pivotal role for a concerted action among PPARG, PPARGC1A, and INSIG1. Expression of SCD, the
most abundant gene measured, appears to be key during milk fat synthesis. The lack of correlation
between gene expression and calculated desaturase indexes does not support their use to infer
mRNA expression or enzyme activity (e.g., SCD). Longitudinal mRNA expression allowed
development of transcriptional regulation networks and an updated model of milk fat synthesis
regulation.
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Background
Progress in lactation biology of the bovine mammary
gland advanced substantially during the 20th  century
(review by [1]). Early studies with ruminants (1960
through 1980s) defined and quantified major metabolic
aspects of mammary lipid metabolism, including de novo
synthesis and fatty acid (FA) uptake from blood [2]. Milk
lipid synthesis as well as droplet formation and secretion
[3] received particular interest due to their influence on
the manufacturing properties and organoleptic quality of
milk and dairy products. Recent work has been more
focused on qualitative aspects of lipid feeding to manipu-
late milk FA composition. Milk FA profiles and fat produc-
tion are affected by stage of lactation and nutrition [4-6].
The latter, however, is by far the predominant environ-
mental factor affecting milk fat production and it repre-
sents a practical tool to alter the yield and composition of
FA regarded as functional food components (e.g., conju-
gated linoleic acid and omega-3 fatty acids; [1]). Clearly,
deep understanding of mammary physiology and molec-
ular adaptations to diet and/or physiological state are
required for efficient manipulation of milk component
synthesis and development of dairy products with specific
characteristics (e.g., more unsaturated FA, more CLA).
Functional genomics studies highlighted the complexity
and coordinated set of molecular events that encompass
murine (reviewed in [7]), bovine [8], caprine [9], and por-
cine [10] mammary adaptations to lactation, revealing
new insights about the underlying transcriptomic regula-
tion [11]. Until recently bovine functional genomics stud-
ies were not feasible. However, up-to-date bovine genome
sequencing and annotation efforts combined with quan-
titative PCR (qPCR) have become powerful tools for high-
precision gene expression analysis. Genetic engineering
studies in plants have revealed that an increase in meta-
bolic flux requires manipulation of most of the enzymes
in a biosynthetic pathway, challenging the idea of a "lim-
iting enzyme" [12]. Therefore, measurement of mRNA for
multiple genes and their networks in a pathway/s is essen-
tial to enable conclusions about a metabolic process and
its outputs. Previous work in functional genomics also has
reinforced the view that transcriptional regulation of gene
expression is crucial because it is one of the major long-
term regulatory mechanisms of cellular metabolism.
We recognize, however, that mRNA expression is one of
multiple factors to be considered when studying the com-
plex molecular networks working simultaneously in tis-
sues. In fact, the ratio between mRNA abundance and
abundance of the functional protein coded by the mRNA
is hardly 1:1. This has been demonstrated in yeast, espe-
cially for the low abundant proteins [13]. There are
numerous post-transcriptional and post-translational reg-
ulatory steps that preclude from inferring precisely pro-
tein abundance from mRNA. Numerous types of
molecular and chemical relationships also exist which
directly or indirectly (e.g., protein-protein interaction,
phosphorilations) could affect protein activity. The fact
remains that post-transcriptional regulation pertains
more to short- than long-term regulation [14].
One of the long-term goals in our laboratory is to define
gene networks involved in regulating mammary lipid syn-
thesis in dairy cows. As an initial step to characterize these
networks and their behavior, we have studied mammary
tissue mRNA expression across changes in physiological
state. Selected genes included those associated with FA
uptake from blood, intracellular FA activation/channel-
ling, de novo synthesis, desaturation, regulation of tran-
scription, utilization of ketone bodies, phospholipid and
triacylglycerol (TAG) synthesis, lipid globule membrane
formation, as well as novel "lipogenic" genes (see Table 1
for details and gene description). Most of the selected
genes were chosen based on previous studies with mam-
mary tissue [2,6,15,16]. Others have only recently been
discovered and their initial functional characterization
conducted in mammary (e.g. ABCG2 [17]) or other tissues
(e.g. LPIN, [18]). Specific isoforms for several families of
genes involved in TAG synthesis were chosen based on
previous published data from our laboratory [19]. The
biological effect of changes in gene expression was evalu-
ated via milk fatty acid secretion.
Methods
Animals, sampling, and diet
Holstein dairy cows of high genetic merit were used
(Additional file 1, Table S1). Details of the experimental
design were reported previously [20]. Briefly, percutane-
ous biopsies from each of 6 cows were obtained from the
right or left rear quarter of the mammary gland at -15 (-13
± 3), 1, 15, 30, 60, 120, and 240 d relative to parturition.
RNA extraction, PCR, and design and evaluation of 
primers
Specific details of these procedures are presented in the
Additional file 1 (Supplementary Materials and Methods
and Table S2, Table S3, and Table S4).
Data processing and statistical analysis
PCR-normalized data are presented as n-fold change rela-
tive to -15 d. To estimate standard errors at -15 d, and pre-
vent biases in statistical analysis, normalized data were
transformed to obtain a perfect average of 1.0 at -15 d,
leaving the proportional difference between the biological
replicates. The same proportional change was calculated
at all other time points to obtain a fold change relative to
-15 d. This final dataset was analyzed using a MIXED
model with repeated measures in SAS (SAS Inst. Inc. Cary,
NC, release 8.0) to evaluate the effect of time relative toBMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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parturition on gene expression. Compound symmetry
was the most appropriate covariate structure used for
repeated measures analysis. The model included the fixed
effect of time (-15, 1, 15, 30, 60, 120, and 240 d) and the
random effect of cow.
Relative mRNA abundance among transcripts
Efficiency of PCR amplification for each gene was calcu-
lated using the standard curve method (E = 10-1/-log curve
slope) (Additional file 1, Table S5). Relative mRNA abun-
dance among measured genes was calculated as previ-
ously reported [19], using the inverse of PCR efficiency
raised to ΔCt (gene abundance = 1/EΔCt, where ΔCt = Ct
sample - geometric mean Ct of 3 internal control genes).
Overall mRNA abundance for each gene among all sam-
ples measured was calculated using the median ΔCt. Use
of this technique for estimating relative mRNA abundance
among genes was necessary because relative mRNA quan-
tification was performed using a standard curve (made
from a mixture of RNA from several bovine tissues [20]),
which precluded a direct comparison among genes.
Together, use of Ct values corrected for the efficiency of
amplification plus internal control genes as baseline over-
come this limitation. Description of genes measured and
overall % relative mRNA abundance are reported in Table
1.
Milk yield, composition and fatty acid analysis
Specific details regarding measurement of milk yield,
composition, and fatty acid analysis are presented in the
Additional file 1. Daily yield of fatty acids (mole/d) syn-
thesized de novo was calculated by the sum of FA 4-14-car-
bon FA, and yield of FA taken up from blood by the sum
of 18-24-carbon FA. The index of acetyl-CoA incorporated
during FA elongation (ACE or FA synthesis from acetyl-
CoA) was calculated as suggested previously [5] with
Table 1: Gene symbol, description, and overall % mRNA abundance among genes investigated
FA import into cells % RNA1 Triacylglycerol synthesis % RNA
LPL Lipoprotein lipase 9.56 GPAM Glycerol-3-phosphate acyltransferase, 
mitochondrial
2.31
CD36 CD36 molecule (thrombospondin receptor) 4.66 AGPAT6 1-acylglycerol-3-phosphate O-acyltransferase 6 1.28
VLDLR Very-Low Density Lipoprotein Receptor 0.09 DGAT1 Diacylglycerol acyltransferase 1 0.14
Xenobiotic and Cholesterol transport DGAT2 Diacylglycerol acyltransferase 2 <0.01
ABCA1 ATP-binding cassette, sub-family A (ABC1), 
member 1
0.07 LPIN1 Lipin 1 0.13
ABCG2 ATP-binding cassette, sub-family G (WHITE), 
member 2
8.54 Regulation of transcription
Acetate and FA activation and intra-cellular 
transport
INSIG1 Insulin induced gene 1 0.35
ACSS1 acyl-CoA synthetase short-chain family member 1 0.33 INSIG2 Insulin induced gene 2 0.09
ACSS2 acyl-CoA synthetase short-chain family member 2 0.59 SCAP SREBP cleavage activating protein 0.13
ACSL1 Acyl-CoA synthetase long-chain family member 1 0.89 SREBF1 Sterol regulatory element-binding transcription 
factor 1
0.15
ACBP Acyl-CoA binding protein 
(diazepam binding inhibitor)
0.17 SREBF2 Sterol regulatory element-binding transcription 
factor 2
0.10
FABP3 Fatty acid-binding protein, heart 15.49 THRSP Thyroid hormone responsive SPOT14 0.01
Fatty acid synthesis and desaturation PPARG Peroxisome proliferator-activated receptor 
gamma
0.01
ACACA Acetyl-coenzyme A carboxylase alpha 0.91 PPARGC1A PPAR gamma, coactivator 1 alpha 0.04
FADS1 Fatty acid desaturase 1 (delta-5 desaturase) 0.20 PPARGC1B PPAR gamma, coactivator 1 beta 0.01
FADS2 Fatty acid desaturase 2 (delta-6 desaturase) <0.01 Sphingolipid synthesis
FASN Fatty acid synthase 7.05 SPTLC1 Serine palmitoyltransferase, long chain base 
subunit 1
0.15
SCD Stearoyl-CoA desaturase (delta-9-desaturase) 23.14 SPTLC2 Serine palmitoyltransferase, long chain base 
subunit 2
0.15
Lipid droplet formation LASS2 LAG1 homolog, ceramide synthase 2 0.61
ADFP Adipose differentiation related protein 
(adipophilin)
9.56 SPHK2 Sphingosine kinase 2 0.09
BTN1A1 Butyrophilin, subfamily 1, member A1 4.78 ASAHL N-acylsphingosine amidohydrolase-like 0.05
XDH Xanthine dehydrogenase 7.39 SGPL1 Sphingosine-1-phosphate lyase 0.06
PLIN Perilipin 0.01 UGCG Ceramide glucosyltransferase 0.18
Ketone body utilization OSBP Oxysterol-binding protein 1 0.12
BDH1 3-hydroxybutyrate dehydrogenase, type 1 0.02 OSBPL2 Oxysterol binding protein-like 2 0.17
OXCT1 3-oxoacid CoA transferase 1 0.07 OSBPL10 Oxysterol binding protein-like 10 0.06
1 The % mRNA abundance is calculated by [((1/EΔCt) specific gene/sum (1/EΔCt) all genes) × 100]. See Materials and Methods for detailsBMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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modifications (see caption in Additional file 1, Table S6
for details).
Gene network analysis
Gene networks were evaluated using Ingenuity Pathway
Analysis®  (IPA; http://www.ingenuity.com, Redwood
City, CA). This is a web-based application that enables the
discovery, visualization, and exploration of interaction
networks. The software relies on currently known rela-
tionships (i.e., published manuscripts) among human,
mouse, and rat genes/proteins.
Results and Discussion
Milk fatty acid composition: a functional analysis
Lactation patterns of FA synthesized vs. FA taken up (Fig-
ure 1, top panel) suggest that uptake from blood predom-
inated during the first mo of lactation. Calculation of
synthesized FA (Figure 1, top panel) and ACE data (Table
2) suggest that synthesis of FA from acetate or butyrate
began during the first 2 wk of lactation and increased rap-
idly thereafter reaching a peak at 30 d. Thus, we concluded
based also on ratio of synthesized/imported (Figure 1, top
panel, Table 2) that de novo FA synthesis predominated
after 1st mo post-partum. The simple sum of FA yield (Σ4-
to 14-carbon FA) to estimate amount of FA originating de
novo suffers from the assumption that butyrate in milk is
completely derived from de novo synthesis. Reports indi-
cated that the major part of butyrate (derived from β-
hydroxybutyrate) is incorporated directly into de novo-
synthesized FA (50–60%) [16]. However, a considerable
portion also is esterified directly into the sn-3 of TAG
[2,21]. Pattern of ACE (Table 2) corresponded with pat-
tern of ACACA  (acetyl-coenzyme A carboxylase alpha)
and FASN (fatty acid synthase) expression (peaked at 60
d, see "Concerted action between de novo FA synthesis and
desaturation in mammary TAG synthesis" section for
details), both of which are key enzymes regulating de novo
synthesis. Additional discussion on milk FA composition
is available in Additional file 1 (Supplementary Results
and Discussion).
Fatty acid uptake by mammary cells
LPL and VLDLR and exogenous FA utilization
Mammary cells take up LCFA from albumin-bound fatty
acids (NEFA) and lipoproteins. VLDL or chylomicrons are
anchored to mammary endothelium by lipoprotein lipase
(LPL), which then hydrolyzes TAG in the lipoprotein core
to release FA [22]. LPL has higher activity in mammary
[22] compared with other tissues, probably due to its high
mRNA abundance. The observed up-regulation in LPL
mRNA as early as the onset of milk synthesis was remark-
able (Figure 2) because mouse mammary tissue had only
a 2-fold increase in LPL transcript between pregnancy and
lactation. In the mouse, the increase was accompanied by
2-fold up-regulation of enzymatic activity [23,24]. In con-
trast with murine, bovine mammary LPL expression pat-
tern was remarkably similar to the lactation curve
(Additional file 1, Figure S1), which might be indicative of
an important role of this gene in maintenance of milk syn-
thesis.
Recent evidence points at VLDL receptor (VLDLR) as an
essential component of LPL activity [25]. VLDLR expres-
sion was up-regulated throughout lactation, particularly
in the first mo post-partum (Figure 2). The mRNA abun-
dance of LPL and VLDLR accounted for ~10% and ~0.1%
of total genes measured (Table 1). Despite these differ-
De novo vs. imported FA and Δ9 desaturase indexes Figure 1
De novo vs. imported FA and Δ9 desaturase indexes. 
De novo FA synthesis (Synthesized) vs FA import (Imported) 
analysis (Top panel) and Δ9 desaturase indexes during lacta-
tion (Bottom panel). Synthesized = FA with 4÷14 carbons 
except 11:1; pooled SEM = 0.34. Imported from blood = FA 
with carbon chain >16 plus 15:0 and 11:1; pooled SEM = 
0.31. Synthesized/Imported, pooled SEM = 0.10. Pooled SEM 
for Δ9 activity on 14:0, 16:0, 18:0, and trans11-18:1 was 0.008, 
0.007, 0.02, and 0.06, respectively. Statistical effect of time: P 
< 0.05 for all measurements except Synthesized FA (P = 
0.24) and Δ9 activity on 18:0 (P = 0.77).
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Table 2: % FA from blood, synthesized de novo, and calculated incorporation of acetyl-CoA into de novo synthesized FA (ACE)1
Day relative to parturition
Item 15 30 60 120 240 SEM P-Value2
Synthesized FA %3 46.4a 48.9ab 53.5bc 57.8c 52.8abc 2.08 < 0.01
FA from blood %4 53.6c 51.1bc 46.5ab 42.2a 47.2abc 2.08 < 0.01
ACE mol/d5 5.2a 14.0b 13.8b 12.9b 12.0b 1.46 < 0.01
ACE mol/d6 4.9a 13.7b 13.5b 12.6b 11.7b 1.42 < 0.01
Δ9-Desaturase index7 0.35b 0.33b 0.30ab 0.27a 0.30ab 0.17 < 0.01
1 The complete FA datasets (mole/day and g/100 g) are reported in Additional file 1 (Tables S6 and S7).
2Effect of day.
3 Fatty acid with carbon length 4÷14 (except 11)/tot FA (except 16:0 and 16:1).
4 Fatty acid with carbon length >16 (included 11 and 15)/tot FA (except 16:0 and 16:1).
5 ACE corrected (Additional file 1, Table S6).
6ACE corrected without considering odd chain FA (11:0, 15:0) (Additional file 1, Table S6).
7 Overall Δ9 desaturase index, calculated from (14:1 c9 + 16:1 c9 + 18:1 c9 + 18:2 c9, t11)/(14:0 + 14:1 c9 + 16:0 + 16:1 c9 + 18:0 + 18:1 c9 + 18:1 
t11 + 18:1 c9, t11)
a,b,c denote P < 0.05
Genes involved in FA uptake, activation, intracellular trafficking, and xenobiotic and cholesterol transport Figure 2
Genes involved in FA uptake, activation, intracellular trafficking, and xenobiotic and cholesterol transport. 
Temporal expression patterns in bovine mammary of genes involved in FA uptake (LPL, SEM = 8.0; CD36, SE = 0.97; VLDR; SEM 
= 0.72), FA and acyl-CoA transport (FABP3, SEM = 6.18; ACBP, SE = 0.11), short- and long-chain FA activation (ACSS1, SEM = 
0.95; ACSS2, SEM = 1.66; ACSL1, SEM = 0.61), and xenobiotic and cholesterol transport (ABCA1, SEM = 0.22; ABCG2, SEM = 
2.69). Statistical effect of time: P < 0.05 for all genes except ABCA1 (P = 0.06).
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ences, data suggest an important role for VLDLR in concert
with LPL [25] in milk fat synthesis during lactation. Mam-
mary VLDLR could act on chylomicrons or intestinal
VLDL, which contain apo-B48 [26]. In general, our data
are in agreement with previous work reporting higher effi-
ciency of mammary TAG uptake from lipoproteins at the
beginning of lactation [26]. The pattern of mammary tis-
sue expression of LPL during lactation was in accordance
with the typical increase in blood LDL in dairy cows post-
partum, which is an indirect index of VLDL utilization
[27].
FAT/CD36 and FA internalization
Passive diffusion of FA across membranes plays a minor
role compared with protein-mediated FA uptake and the
flip-flop mechanism [28]. The main proteins involved in
FA uptake in non-ruminant cells include fatty acid trans-
locator FAT/CD36 (CD36) and fatty acid transport pro-
teins (FATP or SLC27A) [28]. CD36 mRNA in our study
accounted for ~5% of total genes measured (Table 1) and
had a large increase in expression (>8-fold) during lacta-
tion (Figure 2). This protein is believed to participate in
the process of milk fat secretion [3] because of its presence
in the milk fat globule membranes (MGFM) [29]. Our
data support an important role for CD36 in milk fat syn-
thesis. Although a role for this gene in milk fat secretion
cannot be excluded we believe that its involvement in FA
import in bovine mammary cells is more important.
We previously showed that bovine mammary tissue
expresses most of the known SLC27A isoforms, but only
expression of SLC27A6 was up-regulated during the first
mo of lactation suggesting a role in NEFA uptake [19]. Up-
regulation in expression of SLC27A6 and CD36, and the
fact that their proteins co-localize in murine heart subcel-
lular fractions, support the concept of cooperation
between both proteins during FA uptake. CD36 also co-
localizes with acyl-CoA synthetases (ACSL) and fatty acid
binding proteins (FABP) [30]. Clearly, FA uptake by
bovine mammary cells is a complex and coordinated
mechanism requiring evaluation of multiple genes/pro-
teins.
Activation and intracellular channelling of FA
ACSL1 and ACSS2 and FA activation for milk TAG
Long-chain FA (LCFA) are esterified with CoA in the inner
face of the plasma membrane prior to participating in
metabolic pathways. FA activation occurs primarily via
acyl-CoA synthetase long-chain family member isoforms
(ACSL) [31]. ACSL1 mRNA is predominant among ACSL
isoforms in bovine mammary tissue [19], and it increased
>4-fold at the onset of lactation suggesting this isoform is
important for copious milk fat synthesis (Figure 2).
Among enzymes involved in activation of short chain FA
(SCFA), acyl-CoA synthetase short-chain family member
2 (ACSS2) had greater mRNA abundance and up-regula-
tion in expression than ACSS1 (a.k.a. ACAS2L). mRNA
abundance of ACSS1, ACSS2, and ACSL1 in each case was
<1% of genes investigated (Table 1). Bovine ACSS iso-
forms have been isolated and characterized in tissues
other than mammary [32]. In the mouse, ACSS isoforms
only have 43.8% amino acid similarity and are located in
different cell compartments. ACSS2 (originally named
AceCS1) is exclusively present in cytosol, while ACSS1
(originally named AceCS2) is primarily found in mito-
chondria [32]. Both enzymes have high affinity for ace-
tate, with ACSS2 showing greater affinity than ACSS1. The
latter also has modest affinity for propionate [32].
Bovine ACSS1 activated >4-fold more 14C-acetate into
CO2 than lipid, suggesting it targets acetate towards oxida-
tion [32]. Human ACSS2 was shown to channel acetate
towards FA synthesis [33]. In our study, both ACSS1 and
ACSS2  mRNA increased substantially during lactation
(Figure 2). ACSS2 transcript pattern corresponded with
bovine mammary acetyl-CoA production throughout lac-
tation [34]. Thus, its large increase at the onset of lactation
along with the pattern of ACE during the first 60 d post-
partum, suggest the protein encoded by this gene provides
activated acetate for de novo FA synthesis. In addition to its
use in FA synthesis, acetate is the chief carbon source for
energy generation in mammary accounting for ~33% of
total CO2 produced by the tissue [35]. Lower mRNA abun-
dance and pattern of expression of ACSS1 throughout lac-
tation is in agreement with acetate use for oxidation [2].
Overall, ACSS isoforms expression reflected the need for
activation of acetate in mammary tissue.
FABP3 and FA trafficking towards milk TAG
Free diffusion of LCFA into cells is too slow to account for
the rapid transport and selective targeting towards specific
organelles [36], thus, LCFA require specific transporters.
Fatty acid binding protein (FABP) and acyl-CoA binding
protein (ACBP or DBI) are the main intracellular FA trans-
porters in non-ruminant cells [36]. The former has high
affinity for LCFA but also can bind acyl-CoA [37,38].
ACBP is the major intracellular transporter of acyl-CoA in
several mammalian tissues [39]. We previously observed
the presence of mRNA of all FABP isoforms, except FABP2
mRNA, in bovine mammary tissue with greater abun-
dance and up-regulation of FABP3 mRNA during lacta-
tion. Transcript of FABP4  and  FABP5  also were up-
regulated during lactation but were less abundant com-
pared with FABP3 [19]. In the present study, FABP3 was
the second most abundant transcript (~16%) among all
measured, in accord with the large cytosolic content of its
protein in mammary epithelium [38]. The large mRNA
abundance of this gene also was a consequence of the 80-
fold up-regulation during lactation, whereas ACBP mRNA
abundance was <0.2% among all genes and had a smallBMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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increase (1.5-fold) during lactation (Table 1 and Figure
2). Low ACBP  mRNA abundance agrees with protein
abundance data in bovine mammary [40]. Our results
suggest a minor role of ACBP in bovine mammary lipid
synthesis, also supported by murine data [23].
In addition to a trafficking role, FABP3 through binding of
activated acyl-CoAs could buffer cells from negative
effects of activated FA and prevent inhibition of ACACA
and SCD (stearoyl-CoA desaturase), roles usually attrib-
uted to ACBP [39]. A positive relationship between FABP
and SCD has been demonstrated in chickens [41], indicat-
ing a coordinated function between both proteins in
mammary tissue as also suggested previously from an
evaluation of published data [6]. Based on our longitudi-
nal mRNA expression and fatty acid data we propose that
an important function of FABP3 in bovine mammary is to
provide FA for SCD. Large affinity of FABP4 for oleic acid
and up-regulation of its mRNA during lactation in bovine
mammary tissue [19], led us to propose that FABP3 pro-
vides stearoyl-CoA (or other substrates such as 16:0 and
trans11-18:1) [38] to SCD which then releases oleic acid
to FABP4. The FA are then available to other enzymes
involved in TAG synthesis.
Membrane-associated ATP transporters
ABCG2 and its potential role in milk synthesis
We observed a 30-fold increase in ABCG2 [ATP-binding
cassette, sub-family G (WHITE), member 2] transcript
during lactation (Figure 2). mRNA abundance of this gene
accounted for ~9% of total genes measured (Table 1).
ABCG2 is a member of the large ATP binding cassette fam-
ily of membrane-spanning efflux pumps that actively
extrude a wide range of xenobiotics [42]. It is present in
apical membrane of murine mammary alveolar epithelia
and plays a role in active secretion of toxins into milk
[42]. It also is present in the milk fat globule membrane
(MFGM) [29], probably in the external bilayer originating
from plasma membrane, due to its apical membrane
localization. The large ABCG2 mRNA abundance and up-
regulation, both in lactating bovine and murine mam-
mary tissue [17,23], is biologically puzzling because the
primary role of this transporter in other tissues is detoxifi-
cation. Recently, it was reported that one amino acid sub-
stitution at position 581 (Tyr to Ser; Y581S) of ABCG2
resulted in decreased milk production but increased milk
fat and protein concentration and yield [43]. Those data
clearly do not support a role of ABCG2 in synthesis or
secretion of milk fat. What seems apparent based on cur-
rent bovine data is that ABCG2 plays an essential role in
secretion of "some" important milk constituent [42].
Cholesterol transport was suggested [43] but it is not sup-
ported by the low amount [3] and pattern of cholesterol
in bovine milk throughout lactation [44]. The only dem-
onstrated role of ABCG2 in secretion of a milk component
is for riboflavin, an essential, but quantitatively marginal,
nutrient for the neonate [17]. Therefore, its large up-regu-
lation is suggestive of other functions in milk synthesis
besides riboflavin secretion.
The amount and pattern of cholesterol secretion into
bovine milk agrees with the pattern of ABCA1 (ATP-bind-
ing cassette, sub-family A, member 1) transcript we
observed (Figure 2). ABCA1 mRNA accounted for <1% of
all genes measured (Table 1). This gene also has low
expression in a number of other bovine tissues, and
bovine mammary in particular [45]. ABCA1 is crucial for
efflux of cholesterol from cells [46]. Taken together, data
suggest a minor role of ABCA1 in bovine mammary cho-
lesterol flux.
Concerted action between de novo FA synthesis and 
desaturation in mammary TAG synthesis
ACACA, FASN, and de novo FA synthesis
Production of SCFA and palmitate from acetate is under
control of ACACA, considered the rate-limiting step in de
novo FA synthesis [2]. In subsequent steps, both, acetyl-
CoA and butyryl-CoA (mostly from plasma β-hydroxybu-
tyrate) are primers for the cytosolic multifunctional pro-
tein fatty acid synthase (FASN) [16]. The major product of
FASN is palmitate but in ruminants the enzyme also pro-
duces SCFA [16]. In the present study, ACACA  mRNA
abundance accounted for <1% whereas FASN accounted
for 7% of total genes measured (Table 1). However,
ACACA mRNA had greater up-regulation during lactation
compared with FASN (Figure 3). These data are consistent
with activity values of the two enzymes from pregnancy
through lactation in dairy cows [34]. Despite differences
in magnitude, expression patterns among both genes were
similar (r = 0.90; P < 0.01; see Excel File in Additional file
2), confirming previous findings summarized in a recent
review article [6]. In fact, this was the case for several genes
involved in TAG synthesis and transport. Clearly, bovine
mammary lipid synthesis requires coordinate expression
of several genes for TAG synthesis and secretion. This
point was stressed in studies of rabbit mammary lipid
metabolism several decades ago [47]. However, the scope
of enzymes studied previously was relatively small com-
pared with our study.
Stearoyl-CoA desaturase and milk TAG synthesis
Only a fraction of FA taken up by the mammary gland is
unsaturated owing to extensive ruminal biohydrogena-
tion. The primary enzyme involved in monounsaturated
FA synthesis is stearoyl-CoA desaturase (SCD), which
introduces a double bond in the Δ9 position of myristoyl-
, palmitoyl-, and stearoyl-CoA, primarily [48]. To date,
two SCD isoforms have been identified and characterized
in bovine: SCD1 and SCD5. SCD1 was first characterized
in bovine adipose [49] and until the discovery of SCD5, itBMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
Page 8 of 21
(page number not for citation purposes)
Genes involved in de novo FA synthesis, LCFA desaturation, TAG synthesis, lipid droplet formation, and BHBA utilization Figure 3
Genes involved in de novo FA synthesis, LCFA desaturation, TAG synthesis, lipid droplet formation, and BHBA 
utilization. Temporal expression patterns in bovine mammary of genes involved in de novo FA synthesis (ACACA, SEM = 0.62; 
FASN, SEM = 0.33), long-chain FA desaturation (SCD, SEM = 6.20; FADS1, SEM = 1.74; FADS2, SEM = 0.36), TAG synthesis 
(GPAM, SEM = 0.96; AGPAT6, SEM = 1.24; LPIN1, SEM = 3.9; DGAT1, SEM = 0.16; DGAT2, SEM = 0.86), lipid droplet formation 
(ADFP, SE = 0.23; BTN1A1, SEM = 1.10; PLIN, SEM = 1.29;XDH, SEM = 0.90), and ketone body utilization (BDH1, SEM = 8.60; 
OXCT1, SEM = 0.54). Statistical effect of time: P < 0.05 for all genes except PLIN (P = 0.17) and DGAT2 (P = 0.54).
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was believed to be the only SCD present in this species.
Thus, the bovine gene is simply referred to as SCD. Bovine
SCD5 has been identified and characterized only recently
[50] and it is expressed almost exclusively in brain. The
nucleotide sequence for a bovine SCD6 homolog A (S.
cerevisiae) has been deposited at NCBI [51], but no char-
acterization of this isoform has been performed to date.
SCD1 has 33.5% and 31.3% global nucleotide alignment
identity [52] with SCD5  and  SCD6, respectively. The
primer pair used in the present study (Additional file 1,
Table S2) is specific only for SCD1. The SCD mRNA abun-
dance was the highest (23%; Table 1) among all genes
measured. The large SCD mRNA abundance, relative to
other classical lipogenic genes (e.g., ACACA, FASN), and
the >40-fold up-regulation during lactation (Figure 3)
agrees with the suggestion by Kinsella, based on lactating
mammary SCD activity [53], that it plays a crucial role in
TAG synthesis.
All indexes of "apparent" desaturase activity increased
during lactation except for stearic acid and palmitic acid
desaturation. The latter index had a peak at the beginning
of lactation followed by a dramatic decrease (Figure 1,
bottom panel). The pattern of SCD mRNA was not signif-
icantly correlated with any of the Δ9 desaturase indexes
(Additional file 2), and was nearly opposite to the overall
Δ9  desaturase index (Table 2). A lack of correlation
between desaturase indexes and SCD desaturase activity
was found previously in bovine intramuscular fat [54],
which along with our findings suggests that use of indexes
is inappropriate for inferring SCD gene expression/activity
at least when considering the lactation cycle [4]. Previous
single-time point studies observed a positive correlation
between SCD mRNA in goat mammary tissue and milk fat
oleic acid [55] or desaturase indexes [56]. In our study,
relative % mRNA abundance of SCD (23%; Table 1) was
related to the total amount of Δ9 FA (14:1c9 + 16:1c9 +
18:1c9 + cis9, trans11-18:1), which accounted for 19% of
total milk FA (molar proportion; Additional file 1, Table
S6).
Overall, our results support a central function of SCD in
milk fat synthesis as previously demonstrated by intrave-
nous infusions of sterculic acid, an inhibitor of SCD activ-
ity [57]. This point is supported, to some extent, by the
recent discovery that both SCD  and  DGAT1  polymor-
phisms affect saturation level of milk fat and largely
explain genetic variance on the desaturase indexes. The
effect, however, was greater for SCD  and primarily on
medium/long-chain FA (from 10- to 16-carbon FA). Poly-
morphism in DGAT1 explained less variability but had a
greater effect on long-chain FA (18-carbon) [58].
The lack of correlation between temporal desaturase
indexes (i.e., apparent SCD activity) and SCD  mRNA
expression is not surprising due to the many factors that
likely play a role in determining milk FA output. An
important factor to consider is the selective uptake of
stearic acid from blood VLDL by the mammary gland
[59]. Mammary tissue relies heavily on utilization of
VLDL-TAG during lactation [27]. Another key aspect is the
high concentration of oleic acid, both in plasma at mid-
lactation [60] and the NEFA pool at early lactation [61].
Oleic acid is the predominant FA in ER membranes [62]
and Δ9 desaturase is essential for their functional mainte-
nance [48]. FABP3 expression and activity also could play
a role in preferential channelling of palmitic and stearic
acid for desaturation. Bovine FABP3 has a high affinity for
both stearic and palmitic acid [38,63].
Very long-chain fatty acid desaturases
Synthesis of very-long-chain FA is carried out by fatty acid
desaturase 1 (FADS1) and 2 (FADS2), which add double
bonds at the Δ5 and Δ6 position of PUFA. Arachidonic acid
(20:4n-6), eicosapentaenoic acid (20:5n-3), and docosa-
hexaenoic acid (22:6n-3) are synthesized via FADS1 and
FADS2 [64,65]. FADS1 and FADS2 mRNA abundance was
<1% of total genes measured (Table 1). The greater rela-
tive mRNA abundance of FADS1 compared with FADS2 is
similar to the one reported in rat mammary [65]. Relative
mRNA abundance in bovine mammary tissue was in con-
cordance with the amount of product of both enzymes,
which accounted only for 0.12% and 0.03% of total milk
FA (Additional file 1, Table S6). FADS1 mRNA expression
increased 18-fold by d 60 postpartum, whereas FADS2
mRNA increased only 3-fold (Figure 3). Expression pat-
tern of FADS1 mRNA did not agree with the observed Δ5
desaturase index, whereas FADS2  mRNA had a similar
pattern compared with its index of activity (Additional file
1, Figure S2). In practical terms, it appears that FADS1
mRNA abundance/activity might be more amenable to
dietary manipulation in order to increase omega-3/
omega-6 ratio in milk fat.
Formation of TAG and milk lipid droplets
Role for AGPAT6 and LPIN1 in TAG synthesis
Discrete steps in the pathway of TAG synthesis [66] have
been discerned in classical lipogenic tissues (e.g., liver,
adipose; [67]) and, despite lack of functional studies of
mammary lipin, the same steps likely apply to the mam-
mary gland. Expression of GPAM (glycerol-3-phosphate
acyltransferase, mitochondrial), AGPAT6 (1-acylglycerol-
3-phosphate O-acyltransferase 6), DGAT1 (diacylglycerol
acyltransferase 1), and LPIN1 (lipin 1) mRNA accounted
for >2%, >1%, ~0.1%, and ~0.1%, respectively, of total
transcripts measured (Table 1). DGAT2 mRNA expression
was nearly undetectable. Despite these differences, we
observed that LPIN1 mRNA was up-regulated during lac-
tation by 20-fold (Figure 3). The more abundant GPAM
and AGPAT6 mRNA increased by 10- and 15-fold by d 60BMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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post-partum (Figure 3). GPAM expression agrees with the
greater enzyme activity in mammary gland during lacta-
tion in non-ruminants (e.g., [47]), and confirms its crucial
role in TAG synthesis [16]. AGPAT6 and LPIN1 are the
major isoforms within each gene family in bovine mam-
mary tissue [19]. When the former was knocked out in lac-
tating mice, they failed to synthesize milk fat [68].
Recent characterization of AGPAT6 showed that this gene
is in fact the ortholog of human GPAT4 (microsomal glyc-
erol-3-phosphate acyltransferase 4) [69]. The product of
GPAT4 did not have AGPAT activity but instead a clear
glycerol-3-phosphate acyltransferase activity [69]. How-
ever, authors failed to demonstrate an increase in TAG
synthesis after overexpression of GPAT4. Despite these
results in the mouse, our data support an important role
of AGPAT6 in bovine mammary and very likely in TAG
synthesis, as previously discussed [19]. Our data seem to
suggest that AGPAT6 has AGPAT activity. This is inferred
by the lower mRNA abundance and temporal increase in
the transcript of other AGPAT in bovine mammary tissue
[19], as well as the large up-regulation of GPAM expres-
sion. It seems unlikely that bovine mammary tissue
would require a larger number of enzymes with GPAT
activity relative to other downstream FA acylating
enzymes.
A potential function of LPIN1 in regulation of transcrip-
tion of other genes involved in milk fat synthesis cannot
be excluded. Recently, it was demonstrated that LPIN1 is
essential for PPARα [70] activation but it also interacts
with PPARγ [71]. In addition, LPIN1 is a target of insulin-
stimulated phosphorylation through mTOR [72], which
in turn seems to promote microsomal vs. cytosolic locali-
zation of the protein. It could be possible that in bovine
mammary tissue insulin signalling through INSR (insulin
receptor) and IRS1 (insulin receptor substrate-1) as well
as mTOR (FRAP1), all of which had a significant increase
in mRNA expression (1.5-4-fold) through lactation [8],
induces LPIN1 phosphorylation and localization to ER for
DAG synthesis and TAG formation.
Relative mRNA abundance of DGAT1 was 17-fold greater
compared with DGAT2 (Table 1) and had modest up-reg-
ulation particularly in early lactation (Figure 3). The tem-
poral pattern in expression of this gene was similar to
butyrate yield (Additional file 1, Table S7). DGAT1
acylates the sn-3 position of DAG and most butyrate in
milk TAG is found here [44]. This protein has high affinity
for butyryl-CoA and even higher for palmitoyl-CoA [73].
However, DGAT1 might favour use of butyrate for the sn-
3 position of DAG as indicated by the larger affinity of
AGPAT for LCFA in mammary [74] along with the prefer-
ential incorporation of palmitic acid in the sn-1 and sn-2
position [3].
The pattern of DGAT1 expression was unexpected because
it is considered a QTL [75] for milk production traits, and
is essential for murine mammary gland development and
milk synthesis [76]. Data from the present study (i.e.,
fold-change and mRNA abundance) suggest that DGAT1,
compared with other genes involved in TAG synthesis, is
of minor importance in the overall process of milk fat syn-
thesis. The temporal decrease or lack of increase in expres-
sion of Dgat1  in mammary tissue of FVB mouse [23]
provides additional support. We do not, however, believe
our findings contradict previous functional studies [77],
demonstrating a pivotal role for DGAT1 in increasing
milk TAG. The fact remains that DGAT1 is one of many
proteins composing the TAG synthesis pathway [67]. A
lack in functionality of any gene in this pathway can likely
reduce the efficiency of TAG synthesis. Protein expression
and functional studies during the entire lactation should
be conducted to clarify the importance of DGAT, and oth-
ers, in mammary lipid synthesis.
Milk lipid droplet formation
Milk fat globules are formed in the ER membrane via
incorporation of newly-formed TAG, transported to the
apical membrane, and eventually released [3]. Well-
defined proteins involved in these processes in mammary
include butyrophilin (BTN1A1), xanthine dehydrogenase
(XDH), and adipophilin (ADFP) [3,15,29]. Relative
mRNA abundance among these genes confirms the large
amount of the respective protein product found in MFGM
[3].  ADFP  mRNA abundance (~10%) relative to other
genes measured was almost twice that of BTN1A1 (~5%)
(Table 1). Expression of BTN1A1,  XDH, and ADFP
increased during lactation and averaged 14-, 8-, and 3-
fold by d 60 postpartum, respectively (Figure 3). The
larger increase in expression of BTN1A1 seems to support
a more crucial role for this gene, as recently suggested
[78], in milk fat secretion compared with XDH and ADFP.
However, despite the greater increase in mRNA expression
for BTN1A1 than ADFP at 60 d post-partum relative to
pre-partum, the larger overall abundance of ADFP tran-
script resulted in similar mRNA abundance for both genes
at 60 d (data not shown). The similar proportion in rela-
tive mRNA of BTN1A1 and ADFP is in accordance with
their protein abundance in mammary tissue [3]. Our
results highlight the limitations of reporting gene expres-
sion data exclusively as n-fold change. Relative mRNA
abundance also needs to be considered. The precise mech-
anism of milk fat secretion is still debated (e.g. [15,78])
but our data confirmed a role for BTN1A1, XDH, and
ADFP. The similar pattern of expression and large correla-
tion observed (r ≥ 0.92, P < 0.01; Supplemental Excel file)
are indicative of a concerted action among the 3 genes
and, thus, provides support for the tripartite model of
murine milk lipid secretion [15].BMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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Perilipins are a family of proteins localized in the periph-
ery of intracellular lipid droplets and are essential for
droplet formation as well as lipolysis in adipose tissue
[79]. ADFP and the perilipin gene (PLIN) are both part of
the perilipin family. Relative PLIN mRNA abundance was
~0.01% of total genes measured (Table 1) and its expres-
sion was only numerically up-regulated (~3-fold by d 60)
during lactation. Our data do not support a significant
role for PLIN in mammary lipid droplet formation. Func-
tional studies could clarify the involvement, if any, of
PLIN in this process.
BDH1 and OXCT1 and utilization of ketone bodies by mammary
β-hydroxybutyrate (BHBA) is the major ketone body pro-
duced in bovine species under most circumstances.
Bovine mammary gland takes up large amounts of BHBA
from blood [80]. Previous studies, focused mostly on de
novo synthesis and oxidation of FA, concluded that use of
BHBA (as 4-carbon units) by mammary cells is primarily
for de novo FA synthesis. A minor portion is used as energy
source through the TCA cycle, leaving unaccounted the
fate of a substantial portion of the BHBA taken up [80].
BDH1 (3-hydroxybutyrate dehydrogenase, type 1) and
OXCT1 (3-oxoacid CoA transferase 1) catalyze the initial
and committed steps of BHBA utilization in mitochondria
[81]. mRNA abundance for BDH1 and OXCT1 accounted
for <0.1% of genes measured (Table 1). The large increase
in expression and relative mRNA abundance during lacta-
tion (Figure 3; Table 1) correspond with their enzymatic
activity level in lactating rat mammary tissue [82]. Based
on these data, and a previous microarray study [8], we
propose that the major fate of BHBA in bovine mammary
is the synthesis of citrate (Additional file 1, Figure S3 for
model and details).
Transcription factors and nuclear receptors during 
lactation: potential roles in mammary lipid metabolism
SREBF-related networks and TAG synthesis
A large body of evidence supports the suggestion that
SREBP1 (sterol regulatory element-binding protein 1) is
pivotal in the regulation of milk fat synthesis in mouse [7]
and cow [83]. SREBP1 and 2 reside as inactive precursors
in the ER membrane and are transported to the Golgi for
proteolytic cleavage (i.e. activation) prior to entering the
nucleus and activation of sterol responsive element-con-
taining genes (e.g., ACACA, FASN). The transport step to
the Golgi is blocked by sterols via the sterol-sensing pro-
tein SCAP (SREBP cleavage activating protein). SCAP is
essential for the movement of SREBP isofoms from the ER
to the Golgi, essentially acting as gate keeper for move-
ment of inactive SREBP1 and 2 [84]. Insulin induced gene
(INSIG) 1 and 2 are proteins that interact with SCAP in an
oxysterol-dependent and independent fashion and regu-
late the responsiveness of SREBP1 and 2 processing via
SCAP, thus altering rates of lipogenesis [84].
Expression of SREBP genes (SREBF1 and SREBF2), and
thyroid hormone responsive SPOT14 (THRSP) averaged
~2-fold by day 60 postpartum (Figure 4) but relative
mRNA abundance was ~0.13% for SREBF1 and SREBF2,
and only 0.01% of total genes measured for THRSP (Table
1). There are two isoforms of SREBP1 (a and c) that can be
expressed at different levels in tissues. The two isoforms
differ by only 84 nucleotides at the first exon [85] and
each appears to be specific in the control of transcription
of genes involved in cholesterol (isoform a) or TAG syn-
thesis (isofom c) [86]. The primer pair used in our study
is unable to differentiate between these because it ampli-
fies mRNA at the 14th exon.
INSIG1, INSIG2, and SCAP mRNA abundance accounted
for ~0.4%, ~0.1%, and ~0.1%, respectively, of total genes
studied (Table 1). These genes had increased mRNA
expression during lactation, ranging from ~1.5-fold for
SCAP to ~12-fold for INSIG1 at or close to peak lactation
(Figure 4). It is apparent from our comprehensive analysis
of SREBF1, in concert with its co-factors (SCAP, INSIG1
and 2), that the complete activation program of SREBP is
up-regulated in the bovine mammary gland during lacta-
tion. More INSIG1 mRNA was expressed in mammary tis-
sue than SCAP or SREBF1 and 2 (Table 1), and its level of
up-regulation reached 10-12-fold between peak through
mid-lactation (Figure 4). If this pattern of INSIG1 mRNA
expression extended to the protein level, more SREBP
might be retained in the ER via SCAP-INSIG1 binding
(i.e., rendered inactive) [84].
INSIG1 binds oxysterols (not cholesterol) specifically and
this specificity is directly correlated with the ability of
these compounds to inhibit SREBP cleavage [84]. Data on
oxysterol concentration/synthesis in bovine mammary
tissue are not readily available but considering that mam-
mary tissue uptake and synthesis of cholesterol is small we
can infer low presence of these compounds. In this regard,
it is interesting that genes coding for oxysterol binding
proteins were up-regulated during lactation (discussed
below). Cleavage inhibition of SREBP also can occur in
the absence of sterols, particularly when the ratio of
INSIG1/SCAP increases as in the present study [84].
Therefore, it appears that an increase of INSIG1 alone can
be enough to block SREBP cleavage. In fact, decreased
SREBP activity as a consequence of increased INSIG1 tran-
script has been observed in liver when INSIG1 is overex-
pressed [87] or during high fat diet-induced INSIG1 up-
regulation [88]. Based on previous results and our data we
postulate that mammary lipid synthesis cannot rely solely
on transcriptional regulation via SREBP1 which is proba-
bly inhibited or controlled by INSIG1.
The observed up-regulation of INSIG1 during lactation
apparently does not make teleological sense becauseBMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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mammary tissue requires substantial up-regulation of
genes involved in de novo lipid synthesis (Figure 1; Table
2). It is striking, however, that INSIG1 mRNA was at its
peak (d 120) when the cows likely were in positive energy
balance, i.e. high blood insulin/glucagon, and the ratio of
de novo-synthesized FA to imported FA was maximal (Fig-
ure 1). INSIG1 expression was positively correlated with
the ratio of synthesized/imported FA (r = 0.38, P < 0.05;
Additional file 2). Paradoxically, these data suggest some
involvement of INSIG1 in inducing FA synthesis. This sug-
gestion is supported by recent data [83], where a decrease
of INSIG1 during experimentally-induced milk fat depres-
sion in lactating cows was observed.
Several factors could drive the marked increase in INSIG1
mRNA during lactation. For example, up-regulation of
INSIG1 expression might be a consequence of SREBF iso-
form mRNA up-regulation and increased activity (i.e.,
induction of gene expression) of the corresponding pro-
teins. SREBP1a and SREBP2 directly regulate INSIG1 gene
expression [84]. Given the lipogenic capacity of mam-
mary tissue, it is more likely that SREBP1c is the more
abundant isoform. Thus, INSIG1 up-regulation in bovine
mammary tissue could be under control of SREBF2 (Fig-
ure 4). Another reason for marked INSIG1 mRNA up-reg-
ulation might be its very short half-life [84], or as a
necessary mechanism to sense low mammary cholesterol
levels in order to regulate de novo FA synthesis.
Our data support a need of INSIG1 in controlling the
induction of gene expression by SREBF isoforms. There-
fore,  INSIG1  could play a central role in orchestrating
lipid metabolism (i.e., TAG vs. cholesterol) in bovine
mammary tissue during lactation. In support of this, it
previously has been suggested that high levels of INSIG1
create a situation in which low levels of endogenous ster-
ols can trigger SCAP binding to INSIG1 without the neces-
sity for exogenous sterols [84]. The "brake" effect of
INSIG1 on TAG accumulation has been clearly demon-
strated in mouse adipose tissue [88], when overexpression
of INSIG1 in 3T3-L1 cells led to a decrease in mRNA abun-
dance of lipogenic genes (e.g. Srebp1c,  Acaca,  Chrebp,
Pparg). Our data, however, do not support a similar effect
of INSIG1 on expression of mammary lipogenic genes in
ruminant.
SREBF2 expression was up-regulated to a greater extent
than SREBF1 expression during lactation (Figure 4). The
reason for up-regulation of SREBF2 expression, and the
similar mRNA abundance compared with SREBF1, is not
apparent because this gene is thought to be involved pri-
marily in cholesterol biosynthesis [85] and the amount of
cholesterol in milk is low [89]. Cholesterol is almost
exclusively synthesized de novo in bovine mammary tissue
[90], thus SREBF2 expression also might be necessary to
Regulation of transcription in bovine mammary Figure 4
Regulation of transcription in bovine mammary. Tem-
poral expression patterns in bovine mammary of genes 
involved in regulation of transcription (SREBF1, SEM = 0.18; 
SREBF2, SEM = 0.36; THRSP, SEM = 0.49; INSIG1, SEM = 1.30; 
INSIG2, SEM = 0.18; SCAP, SEM = 0.08; PPARG, SEM = 0.43; 
PPARGC1A, SEM = 6.6; PPARGC1B, SEM = 0.09). Statistical 
effect of time: P < 0.05 for all genes
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meet cholesterol requirements for MFGM formation [3].
In support of this we observed, via microarray analysis,
that expression of several genes involved in cholesterol
synthesis was significantly up-regulated (1.5-2-fold com-
pare to -30 d) during lactation [8]. An additional function
of SREBP2 is to induce mRNA expression of genes
involved in FA synthesis [85]. It could be possible that
SREBF2 mRNA up-regulation during lactation might com-
pensate for the potential inhibition of INSIG1 on both
SREBP.
Nuclear receptors and the lipogenic program
Genes involved in FA transport such as LPL, CD36, and
ACSL1  are peroxisome proliferator-activated receptor
gamma (PPARγ) target genes [91]. In the lactating mouse,
expression of LPL and ACSL1 was up-regulated signifi-
cantly despite the fact that expression of PPARγ was down-
regulated [23]. However, it has recently been demon-
strated that changes in abundance of adipocytes at several
stages of pregnancy in murine mammary tissue (i.e., high
in early pregnancy vs. low in late pregnancy) could
account for the decrease in PPARγ gene (PPARG) mRNA
abundance [92]. In bovine mammary, PPARG  mRNA
accounted only for 0.01% of total genes measured (Table
1) but was consistently up-regulated during lactation (Fig-
ure 4). The low mRNA abundance of "adipocyte-specific"
genes (e.g., DGAT2, PPARG, ACBP, and PLIN), particu-
larly at the end of pregnancy (i.e. -15 d), clearly indicates
that biopsied cow mammary tissue contained low
amounts of adipocytes. Thus, our longitudinal data on
PPARG expression should represent that of epithelial cells.
With this premise and despite the low mRNA abundance,
up-regulation of PPARG mRNA during lactation suggests
a potential role of this nuclear receptor in milk fat synthe-
sis. A recent study with PPARγ-knockout mice indicated
that absence of PPARG increased utilization of FA for syn-
thesis of inflammatory lipids due to reduced TAG synthe-
sis [93]. A role of PPARG in regulating the entire bovine
milk fat synthesis machinery also is supported by recent
results from our laboratory where treatment of MacT cells
(immortalized bovine mammary epithelial cells) with
rosiglitazone, a specific PPARγ agonist, resulted in coordi-
nated up-regulation in expression of genes involved in FA
import (e.g., CD36), de novo FA synthesis (e.g., ACACA,
FASN, SREBF1), and TAG synthesis (e.g., LPIN1, SCD)
[94].
The relative mRNA abundance for the PPAR gamma coac-
tivators,  PPARGC1A  and  PPARGC1B, was 0.04% and
0.01% of total genes measured (Table 1). Whereas expres-
sion of PPARGC1A  was substantially up-regulated
through d 120 post-partum (~11-fold), expression of
PPARGC1B was consistently down-regulated during the
entire lactation (Figure 4). Differences in relative mRNA
abundance, large temporal up-regulation of PPARGC1A
mRNA, and down-regulation of PPARGC1B  transcript,
suggest an important role of the former in bovine milk fat
synthesis. The importance of PPARGC1A in the overall
process of mammary lipid synthesis likely is more related
to its well-defined role in regulating mitochondrial bio-
genesis and energy metabolism [95]. Up-regulation of
PPARGC1A  during lactation agrees with reported
increases in numbers and turn-over rate of mitochondria
in lactating mammary tissue [21]. Furthermore, our com-
bined data (Table 1, Figure 4) also point to a concerted
action of PPARGC1A and INSIG1. This last observation is
captivating based on previous observations in murine
[96] and bovine mammary epithelial cells [94] where
INSIG1 was demonstrated to be a PPARγ responsive gene,
suggesting that PPARG in mammary tissue could serve as
regulator of SREBP activity.
Ceramide-synthesis genes in bovine mammary tissue
Synthesis of Ceramide in bovine mammary
Ceramide, which is involved in cell signaling, cell cycle,
and regulation of protein transport from ER to Golgi, is
one of the most studied sphingolipids in nature [97,98].
Other sphingolipids with signaling roles include sphingo-
sine (Sph) and sphingosine-1-phosphate (S1P) [98].
Sphingomyelin synthesis from ceramide is important for
milk quality because this compound is considered a func-
tional food component [16]. Although minor compared
with TAG, sphingolipids are the third most important
lipid component [99] in bovine milk fat. MFGM forma-
tion relies on sphingolipid and cholesterol availability
[100], thus coordinated synthesis of both compounds is
pivotal to milk lipid droplet formation/secretion. Sphin-
golipids are involved in lipid synthesis regulation through
their action on SREBP [101]. Mammary tissue synthesizes
sphingolipids de novo [99] from palmitoyl-CoA, leading
to ceramide formation and incorporation into sphingo-
myelin [99]. Thus, palmitic acid used for ceramide synthe-
sis in mammary appears a required step and also might
represent a regulatory point for FA synthesis because cera-
mides can inhibit this process by blocking the activity of
AKT/PKB [102]. Regulation of FA synthesis by sphingoli-
pids in mammary tissue has never been investigated.
Thus, we selected genes crucial in ceramide synthesis/deg-
radation, as well as enzymes involved in Sph and S1P syn-
thesis (Additional file 1, Figure S5) to explore further their
role in lipid synthesis regulation.
In accordance with the minor concentration of sphingoli-
pids in milk, genes in this pathway had low mRNA abun-
dance ranging from 0.05% (N-acylsphingosine
amidohydrolase-like or ASAHL) to 0.61% (LAG1
homolog, ceramide synthase 2 or LASS2) of total genes
examined (Table 1). LASS2  was the most abundant
among sphingolipid-related genes and the only one with
>2-fold up-regulation during lactation (Figure 5). LASSBMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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isoforms are orthologues of the yeast Longevity-assurance
gene. The enzyme is localized in the ER [97] and isoforms
appear to have specific tissue distribution, suggesting they
perform "specialized" functions [19,97]. LASS2 had peak
expression at 60 d postpartum, in agreement with previ-
ous data on milk sphingolipid concentration [99]. Com-
bined data on genes associated with ceramide synthesis
suggest an increase in synthesis coupled with decreased
degradation throughout lactation (Figure 5 and Addi-
tional file 1, Figure S5). An increase in mammary cera-
mide synthesis might potentially serve as a positive signal
for proteins involved in lipid synthesis through activation
of SREBP1 as suggested previously [101]. Increased sphin-
golipid synthesis during lactation also could affect availa-
bility of cholesterol for MFGM, and might explain the
inverse pattern between milk cholesterol ester and sphin-
golipid [99].
Sterol and ceramides and their role in mammary lipid synthesis
Transport of ceramide from ER to Golgi is achieved by
oxysterol binding proteins (OSBP), which also act as
sterol sensors whose function is to integrate cellular sterol
status with sphingomyelin metabolism [103]. A novel
role for OSBP in regulation of lipid synthesis was demon-
strated when overexpression of OSBP led to increases in
TAG synthesis in mouse liver and concomitant up-regula-
tion of SREBF1 and INSIG1 [104]. mRNA abundance of
OSBP  and related genes (OSBPL2,  OSBPL10) in mam-
mary was comparable with that of SREBF1 and 2, and
their expression was up-regulated ~1.5-fold during lacta-
tion (Figure 5) suggesting a functional role, likely involv-
ing the regulation of SREBF1  and the coordination of
sphingolipid and cholesterol synthesis.
Transcription regulation networks and proposed milk fat 
synthesis model
We used our data set to develop gene networks using IPA
(Figure 6). Details of networks are available in Additional
file 1 (Supplementary Materials and Discussion) and the
legend of Figure 6. The resulting networks clearly under-
score a central role for SREBF1, SREBF2, and PPARG in
controlling transcription of most of the genes assessed in
Genes involved in sphingolipid synthesis in bovine mammary Figure 5
Genes involved in sphingolipid synthesis in bovine mammary. Temporal expression patterns in bovine mammary of 
genes involved in sphingolipid synthesis (SPTLC1, SEM = 0.10; SPTLC2, SEM = 0.08; LASS2, SEM = 0.14; SPHK2, SEM = 0.10; 
ASAHL, SEM = 0.10; SGPL1, SEM = 0.13; UGCG, SEM = 0.17; OSBP, SEM = 0.13; OSBPL2, SEM = 0.10; OSBPL10, SEM = 0.09). Sta-
tistical effect of time: P < 0.05 for all genes except SGPL1 (P = 0.63) and SPHK2 (P = 0.65).
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the present study which coordinately regulate milk fat
synthesis. The network also highlights a putative role of
PPARG, in coordination with PPARGC1A and INSIG1, in
controlling function/expression of SREBF1 (highlighted
with orange edges). Thus, our data challenge the notion
that SREBF1 is the central player regulating lipid synthesis
in bovine mammary tissue. We propose that a network of
transcription regulators and nuclear receptors, including
SREBF1, SREBF2, PPARG, INSIG1, and PPARGC1A, coor-
dinate activation of the genes driving the lipid synthesiz-
ing machinery (Figure 6). More functional studies are
clearly needed to determine whether long-term up-regula-
tion of transcription factors and nuclear receptors are
determinant in inducing and maintaining milk fat synthe-
sis. The specific roles of INSIG1 and PPARG during lacta-
tion need to be determined. Besides transcriptional
regulation, other regulatory steps can determine the activ-
ity of the protein. For example, short term regulation of
ACACA activity also occurs at the post-translational level
[105].
Taken together, our findings allowed for the development
of an up-to-date model of milk fat synthesis regulation in
bovine mammary tissue (Figure 7). The model incorpo-
Networks among genes involved in milk fat synthesis Figure 6
Networks among genes involved in milk fat synthesis. Networks were developed with Ingenuity Pathway Analysis® 
(Ingenuity Systems, http://www.ingenuity.com) and edited to incorporate results from the present and previous studies in 
bovine mammary tissue. Red nodes denote positive fold changes and green nodes negative fold changes in expression at 60 rel-
ative to -15 d. Red, blue, and green edges denote genes whose transcription is under the control of SREBF1, SREBF2, and 
PPARG, respectively. Highlighted in orange is the network encompassing PPARG, PPARGC1A, LPIN1, INSIG1, and SCAP which con-
trols expression/function of SREBF proteins. Letters along the edges denote effects on activity (A), expression (E), localization 
(LO), proteolysis (L), RNA binding (RB), protein-DNA binding (PD), and protein-protein binding (PP). Genes are grouped 
based on their primary function during milk fat synthesis.BMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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Interrelationships among cellular pathways regulating milk fat synthesis in bovine mammary tissue Figure 7
Interrelationships among cellular pathways regulating milk fat synthesis in bovine mammary tissue. Detailed 
description of the model is reported in the discussion section. Protein structures, when available, are the most updated from 
ModBase http://modbase.compbio.ucsf.edu/modbase-cgi/search_form.cgi.
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rates the most recent information available, including our
data, on enzymes involved in milk fat synthesis (i.e., sub-
cellular location, fate of FA, and putative role). Following
is the description of the model presented in Figure 7:
 Endothelial long-chain FA (LCFA) transport: the VLDL
TAG core (or chylomicrons) is hydrolyzed by LPL in coop-
eration with VLDLR, which anchor the lipoprotein mole-
cule and releases LCFA for transport across the
endothelium into the extracellular space. LCFA are
imported into mammary cells via flip-flop (passive or
driven by "flippases") and protein-mediated mechanisms.
CD36 appears to be the most important protein regulat-
ing LCFA import, and it might work in concert with FATP6
(SLC27A6). Once LCFA cross the membrane, most are
activated into an LC-acyl-CoA (LCACoA) primarily via
ACSL1 (activation shown by small red dots). Formation
of LCACoA essentially traps LCFA inside the cell and acti-
vates them for subsequent utilization. LCACoA are cap-
tured primarily by FABP3, which transports them to
specific intracellular organelles for utilization.
 FA channelling and metabolic fates: LCFA or LCACoA
bound to FABP3 likely have three primary fates: 1) serve
as substrate for SCD, which inserts a double bound at Δ9
position of the LCFA (primarily 16:0 and 18:0), and the
endogenous FA (primarily oleic acid) is subsequently
transported by FABP4 to enzymes involved in TAG syn-
thesis; 2) serve directly as substrate for TAG synthesis via
sequential reactions carried out by GPAM (LCACoA ⇒ sn-
1 of Glycerol-3-P to form lysophosphatidic acid [LPA]),
GPAM in the present model is located on the ER instead
in the mitochondria, where the proper location for the
product of this gene is. Previous studies have demon-
strated larger microsomal compared with mitochondrial
GPAT activity in lactating bovine mammary tissue [106].
To date, however, only the mammalian mitochondrial
GPAT have been annotated and characterized. The inser-
tion of GPAM in the ER attempts to account for this limi-
tation and to simplify the model. Other enzymes
important for TAG synthesis include AGPAT6 (LCACoA
⇒ sn-2 position of LPA to form phosphatidic acic [PA]),
LPIN1 (cleaves the P group of PA to form diacylglycerol
[DAG]) and to a less extent, DGAT1 (LCACoA ⇒ sn-3
position of DAG to form TAG). The TAG pathway is
denoted by black arrows and encircled by an orange line;
3) can regulate transcription via PPARG (see below).
  Lipid droplet formation: once TAG is formed it is
inserted into the intra-leaflet of the ER membrane to form
lipid droplet. In bovine mammary, ADFP (orange shape)
is central for the formation of lipid droplets and for the
secretory pathway involving BTN1A1 (brown half moon).
The XDH (red circle) also seems to play a role in the mech-
anism encompassing ADFP and BTN1A1.
 De novo FA synthesis, activation, channelling, and for-
mation of TAG and phospholipid: de novo FA synthesis
(encircled in blue) is carried out by ACACA and FASN uti-
lizing acetyl-CoA and butyryl-CoA. Formation of acetyl-
CoA from acetate is carried out by ACSS2. Once FA with
>10-carbons are formed they are activated by ACSL1 and
bound to FABP3, which allows the FA to enter into the
TAG synthesis pathway. Short-chain FA (SCFA) are
inserted into TAG via DGAT1. A portion of palmitate
(both from de novo synthesis and import) can be utilized
for sphingolipid synthesis through ceramide (Additional
file 1, Figure S5).
 Transcriptional regulation: denoted by red arrows. We
propose a role for FABP3 in activation of gene expression
by FA through PPARγ. Besides up-regulation during lacta-
tion, a chief role of PPARG in mammary lipid metabolism
is supported by the large up-regulation in expression of
PPARGC1A and LPIN1 two important PPARγ co-factors.
Regulation of genes involved in de novo synthesis might
partly be under control of SREBP1 (SREBF1), which is
bound to SCAP in the ER and it is transported to the Golgi
where it is cleaved. Activated SREBP1 then enters the
nucleus and could regulate gene expression. However, the
observed up-regulation of INSIG1  (binds SCAP and
blocks SREBP transport to Golgi) could dampen SREBP
activity in bovine mammary during lactation or at the very
least elicit tight regulation of SREBP activity. Our data,
together with previous findings, highlight a possible role
of PPARG in regulating SREBP activity through regulation
of INSIG1 expression (Figure 6). Results support an over-
lapping role of SREBP2 in regulation of expression of gene
involved in de novo FA synthesis. Alternate routes of ace-
tate and butyrate utilization are denoted by green (BHBA)
and orange (acetate) arrows. Up-regulation in expression
of ACSS1 during lactation allow utilization of acetate in
mitochondria for energy generation primarily; whereas,
mRNA up-regulation of BDH1 and OXCT1 allow BHBA
entry into mitochondria. Primary routes of BHBA use are
citrate synthesis (Additional file 1, Figure S3) and mito-
chondrial FA synthesis (Additional file 1, Figure S4).
 Membrane-associated transporters: the marked mRNA
abundance and up-regulation of ABCG2 during lactation
suggest a pivotal role of this gene in milk synthesis/secre-
tion. Demonstrated roles of ABCG2 protein in mammary
tissue include secretion of riboflavin (blue dotted arrow)
and xenobiotics (violet dotted arrow).
Conclusion
Lactation was characterized by dramatic up-regulation in
expression of genes associated with FA uptake from blood
(e.g., LPL, CD36) and intracellular transport/channelling
(e.g., FABP3). These adaptations were mirrored in milk FA
profiles, showing that mammary uptake relative to de novoBMC Genomics 2008, 9:366 http://www.biomedcentral.com/1471-2164/9/366
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synthesis predominated in early lactation. Although of
lower magnitude, lactation also induced up-regulation of
mRNA of genes involved in activation of FA (e.g, ACSL1,
ACSS2), de novo synthesis (e.g., ACACA, FASN), desatura-
tion (e.g., SCD, FADS1), synthesis of TAG (e.g., AGPAT6,
GPAM), lipid droplet formation (e.g., BTN1A1,  XDH),
and ketone body utilization (e.g., BDH1, OXCT1). Tem-
poral expression of genes with well-defined roles in mam-
mary lipid metabolism peaked at 60 d post-partum and to
some extent followed the lactation curve.
We could deduce a central role in endogenous oleic acid
synthesis via SCD for mammary TAG synthesis. However,
there was no statistical correlation between expression
patterns of genes involved in desaturation and (Δ5, Δ6, Δ9)
desaturase indexes rendering their use to infer temporal
enzyme expression/activity meaningless. Furthermore,
expression data highlighted the importance of ketone
body utilization, mitochondrial biogenesis and PPARγ
activity (PPARGC1A), and lipid droplet formation
(BTN1A1, XDH, ADFP) in the global scheme of milk fat
synthesis and secretion (Figure 7). Novel findings
included a likely role for PPARG, LASS2, INSIG1, SREBF2,
and  OSBP  in regulating lipid synthesis and mammary
intracellular equilibrium between cholesterol and sphin-
golipids.
The complexity of mammary molecular adaptations over
time was underscored by gene network analysis (Figure 6)
as well as the apparent interrelationships that must coor-
dinate the overall process of milk fat synthesis and secre-
tion (Figure 7). This point is further exemplified by the
large number of annotated transcripts, among them sev-
eral transcription factors, whose expression is markedly
up-regulated during lactation [8] most of which have cur-
rently unknown functions in bovine mammary tissue.
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